BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 38430974)

  • 1. Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
    Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Randall RL; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; ; Haber M; Marshall G; Cairns MJ; Blay JY; ; Thomas DM; Tattersall M; Neuhaus S; Lewis C; Tucker K; Carey-Smith R; Wood D; Porceddu S; Dickinson I; Thorne H; James P; Ray-Coquard I; Blay JY; Cassier P; Le Cesne A; Duffaud F; Penel N; Isambert N; Kurtz JE; Puri A; Sarin R; Ahn JH; Kim JE; Ward I; Judson I; van der Graaf W; Seddon B; Chandrasekar C; Rickar R; Hennig I; Schiffman J; Randall RL; Silvestri A; Zaratzian A; Tayao M; Walwyn K; Niedermayr E; Mang D; Clark R; Thorpe T; MacDonald J; Riddell K; Mar J; Fennelly V; Wicht A; Zielony B; Galligan E; Glavich G; Stoeckert J; Williams L; Djandjgava L; Buettner I; Osinki C; Stephens S; Rogasik M; Bouclier L; Girodet M; Charreton A; Fayet Y; Crasto S; Sandupatla B; Yoon Y; Je N; Thompson L; Fowler T; Johnson B; Petrikova G; Hambridge T; Hutchins A; Bottero D; Scanlon D; Stokes-Denson J; Génin E; Campion D; Dartigues JF; Deleuze JF; Lambert JC; Redon R; Ludwig T; Grenier-Boley B; Letort S; Lindenbaum P; Meyer V; Quenez O; Dina C; Bellenguez C; Le Clézio CC; Giemza J; Chatel S; Férec C; Le Marec H; Letenneur L; Nicolas G; Rouault K
    Science; 2023 Jan; 379(6629):253-260. PubMed ID: 36656928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, aetiology and implications for management of multiple primary renal tumours: a systematic review.
    Zhang H; Andreou A; Bhatt R; Whitworth J; Yngvadottir B; Maher ER
    Eur J Hum Genet; 2024 May; ():. PubMed ID: 38802529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair.
    Lenain C; Bauwens S; Amiard S; Brunori M; Giraud-Panis MJ; Gilson E
    Curr Biol; 2006 Jul; 16(13):1303-10. PubMed ID: 16730175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome.
    Touzot F; Callebaut I; Soulier J; Gaillard L; Azerrad C; Durandy A; Fischer A; de Villartay JP; Revy P
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10097-102. PubMed ID: 20479256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase.
    van Overbeek M; de Lange T
    Curr Biol; 2006 Jul; 16(13):1295-302. PubMed ID: 16730176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair.
    Lam YC; Akhter S; Gu P; Ye J; Poulet A; Giraud-Panis MJ; Bailey SM; Gilson E; Legerski RJ; Chang S
    EMBO J; 2010 Jul; 29(13):2230-41. PubMed ID: 20551906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection.
    Bories C; Lejour T; Adolphe F; Kermasson L; Couvé S; Tanguy L; Luszczewska G; Watzky M; Poillerat V; Garnier P; Groisman R; Ferlicot S; Richard S; Saparbaev M; Revy P; Gad S; Renaud F
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167107. PubMed ID: 38430974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNM1B/Apollo in the DNA damage response and telomere maintenance.
    Schmiester M; Demuth I
    Oncotarget; 2017 Jul; 8(29):48398-48409. PubMed ID: 28430596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
    Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
    Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shelterin-Mediated Telomere Protection.
    de Lange T
    Annu Rev Genet; 2018 Nov; 52():223-247. PubMed ID: 30208292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumarate hydratase as a therapeutic target in renal cancer.
    Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G
    Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.